RAPTIVA
RAPTIVA
Discontinued
DIN Number
02272504
Drug Class
Human
Market Date
Oct 26, 2005
Company
HC
emd serono, a division of emd inc., canada
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02272504
AIG Number0151549001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
L04AG02 EFALIZUMAB
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationSubcutaneous
AHFS Classification84:92.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
EFALIZUMABActive
Strength: 150 MG / VIAL
Monograph: EFALIZUMAB